Distribution studies with sulfur 35-labeled disulfonamides in tumor-bearing and tumor-free mice.
作者信息
ARGUS M F, SEEPE T L, GUTIERREZ N, HEWSON K, RAY F E
出版信息
Br J Cancer. 1958 Dec;12(4):636-44. doi: 10.1038/bjc.1958.72.
Abstract
摘要
相似文献
1
Distribution studies with sulfur 35-labeled disulfonamides in tumor-bearing and tumor-free mice.在荷瘤小鼠和无瘤小鼠中进行的用硫35标记的二磺酰胺的分布研究。
Br J Cancer. 1958 Dec;12(4):636-44. doi: 10.1038/bjc.1958.72.
2
Distribution of sulfur-35 labeled sulfonic acid derivatives of fluorene in tumor-bearing and tumor-free rats.芴的硫-35标记磺酸衍生物在荷瘤大鼠和无瘤大鼠中的分布。
Br J Cancer. 1962 Mar;16(1):170-6. doi: 10.1038/bjc.1962.18.
3
Sulfur-35 labeled high molecular weight sulfonamides as potential cancer diagnostic and therapeutic agents.作为潜在癌症诊断和治疗剂的硫-35标记的高分子量磺酰胺
Bull Tulane Univ Med Fac. 1961 May;20:151-64.
4
Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor.一种高比活度硫-35标记的磺酰胺放射性配体的研发，该配体使得一种新型生长激素促分泌素受体得以鉴定。
J Med Chem. 1996 Apr 26;39(9):1767-70. doi: 10.1021/jm960054c.
5
Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice.建立一种灵敏的 LC-MS/MS 方法同时测定荷瘤小鼠血浆中的帕瑞昔布及其主要代谢物伐地昔布和羟基伐地昔布，阐明荷瘤小鼠药物代谢降低的原因。
J Pharm Biomed Anal. 2018 Sep 5;158:1-7. doi: 10.1016/j.jpba.2018.05.034. Epub 2018 May 22.
6
In vitro anti-multidrug resistance activities of acyclic and cyclic disulfonamides in murine leukemia cells.
Anticancer Res. 1998 Jul-Aug;18(4C):2961-5.
7
[On the distribution of depot sulfonamides in the liver and skin of the mouse and in the skin and sweat of man].[关于长效磺胺类药物在小鼠肝脏和皮肤以及人体皮肤和汗液中的分布]
Arch Klin Exp Dermatol. 1961;214:123-30.
8
Tumor localization studies with sulfur 35-labeled disulfonamido derivatives of fluorene.用芴的硫35标记的二磺酰胺衍生物进行肿瘤定位研究。
Br J Cancer. 1954 Dec;8(4):698-703. doi: 10.1038/bjc.1954.76.
9
Fluorene derivatives in rats bearing Walker carcinosarcoma.携带沃克癌肉瘤大鼠体内的芴衍生物
Br J Cancer. 1965 Sep;19(3):513-8. doi: 10.1038/bjc.1965.62.
10
[Studies on bacterial affinity for sulfonamides].[关于细菌对磺胺类药物亲和力的研究]
Zentralbl Bakteriol Orig. 1964 Jul;193(2):200-23.
引用本文的文献
1
Distribution of sulfur-35 labeled sulfonic acid derivatives of fluorene in tumor-bearing and tumor-free rats.芴的硫-35标记磺酸衍生物在荷瘤大鼠和无瘤大鼠中的分布。
Br J Cancer. 1962 Mar;16(1):170-6. doi: 10.1038/bjc.1962.18.
2
Effect of rapid tissue growth on the uptake of fluorene-2, 7-di-(sulfonamido-2-naphthalene)-S35 by the liver and spleen of rats and hamsters.快速组织生长对大鼠和仓鼠肝脏及脾脏摄取芴-2,7-二（磺酰胺基-2-萘）-S35的影响。
Br J Cancer. 1962 Sep;16(3):494-502. doi: 10.1038/bjc.1962.57.
3
Distribution of new fluorene disulphonamido derivatives in rats with transplanted Walker carcinosarcoma.新型芴二磺酰胺衍生物在移植Walker癌肉瘤大鼠体内的分布
Br J Cancer. 1966 Dec;20(4):857-70. doi: 10.1038/bjc.1966.99.
本文引用的文献
1
Effect of tumors on liver and spleen uptake of radioactive material.肿瘤对肝脏和脾脏摄取放射性物质的影响。
Br J Cancer. 1956 Jun;10(2):321-3. doi: 10.1038/bjc.1956.38.
2
A physio-pathological study of the rat's stomach and blood after administration of chrysoidine Y and alphaazurine.给予金胺Y和α-天青精后大鼠胃和血液的生理病理学研究
Am J Physiol. 1954 Sep;178(3):493-8. doi: 10.1152/ajplegacy.1954.178.3.493.
3
Distribution of radioactivity following administration of sulfur 35-labelled disodium fluorene-2,7-disulfonate in mice bearing a transplantable stomach carcinoma.给患有可移植性胃癌的小鼠注射硫35标记的芴-2,7-二磺酸钠后放射性的分布情况。
Br J Cancer. 1953 Jun;7(2):273-8. doi: 10.1038/bjc.1953.26.
4
Gastric secretion of fluorene-2-azo-2', 4'-dihydroxybenzene in the rat, mouse, and guineapig.大鼠、小鼠和豚鼠中芴-2-偶氮-2',4'-二羟基苯的胃液分泌
Br J Cancer. 1953 Jun;7(2):264-72. doi: 10.1038/bjc.1953.25.
Zotero 插件